Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does lipitor's use influence blood pressure medication type?Does food increase lipitor's absorption?When genetic tenofovir alafenamide be available in us?How does protein binding influence lipitor's removal via kidneys?Are there specific stretches to avoid while on lipitor?
See the DrugPatentWatch profile for aspirin
Aspirin prevents blood clots by irreversibly inhibiting cyclooxygenase-1 (COX-1) enzyme in platelets, which blocks thromboxane A2 production—a key promoter of platelet aggregation and clotting.[1] A single 81-325 mg dose reduces clotting risk for 7-10 days, as platelets live about that long.[2]
Not taking aspirin leaves platelet function unimpeded, raising clot formation risk, especially in people with cardiovascular disease. Studies show daily low-dose aspirin cuts nonfatal myocardial infarction risk by 34% and stroke by 25% in high-risk patients.[3] Without it, baseline clotting risks return: for secondary prevention post-heart attack or stroke, this means 10-20% higher annual event rates depending on factors like age and comorbidities.[4]
| Option | How It Works | Clot Risk Reduction vs. No Treatment | Bleeding Risk | |--------|--------------|------------------------------|---------------| | No aspirin | Full platelet activity | Baseline (e.g., 2-5% annual CV events in high-risk) | Lowest | | Low-dose aspirin | COX-1 inhibition | 20-30% | Mild increase (1-2% GI bleed/year) | | Clopidogrel (Plavix) | P2Y12 blocker | 20-25%, better in some genetic profiles | Similar to aspirin | | Warfarin/DOACs | Vitamin K or factor Xa inhibition | 60-70% for AF stroke | Highest (3-5% major bleeds) | Switching off aspirin often requires alternatives; abrupt stop in stable patients raises acute clot risk 1.5-2x in first month.[8]
Elective surgery (e.g., dental): Pause 5-7 days pre-op to normalize clotting, as residual effect fades.[9] GI bleed history: Benefits may not justify 50% relative bleed increase.[10] Always consult physicians—self-stopping post-stent can trigger stent thrombosis (5-30% risk).[11] [1] PubMed: Aspirin mechanism [2] NEJM: Platelet lifespan [3] USPSTF Aspirin Guidelines [4] ANTARCTIC Trial [5] AHA/ACC Guidelines [6] CHA2DS2-VASc Score [7] Framingham Risk [8] CESSATION Study [9] ASRA Guidelines [10] COGENT Trial [11] CREDO Trial
Other Questions About Aspirin :